The frequent mutations of the spliceosome machinery were also identified to be one of the most frequently affected pathways in MDS, particularly the mutations in SF3B1, SRSF2, U2AF1, and ZRSR2 [97]. This evidence concerns the gene U2AF1 and myelodysplastic syndrome.